India - English - Central Drugs Standard Control Organization

j.&j. - surgical preparations - bandage - dressing - 15cmx4m

India - English - Central Drugs Standard Control Organization

j.&j. - surgical preparations - bandage - dressing - 6cm.*4m.

India - English - Central Drugs Standard Control Organization

j.&j. - surgical preparations - bandage - dressing - 8cmx4m

Philippines - English - FDA (Food And Drug Administration)

yung shin(philippines), inc.; distributor: dynasty pharmaceuticals - clindamycin (as phosphate) - solution for injection - 150 mg/ml

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

pharma dynamics (pty) ltd - capsule - each tablet contains candesartan cilexetil 8,0 mg

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

pharma dynamics (pty) ltd - capsule - each tablet contains candesartan cilexetil 16,0 mg

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

pharma dynamics (pty) ltd - capsule - each tablet contains candesartan cilexetil 32,0 mg

Philippines - English - FDA (Food And Drug Administration)

yung shin (philippines), inc.; distributor: dynasty pharmaceuticals - clindamycin (as hydrochloride) - capsule - 300mg

Australia - English - Department of Health (Therapeutic Goods Administration)

boston scientific pty ltd - 37265 - defibrillator, implantable, automatic, dual-chamber - dynogen dr-dual-chamber icd combines ventricular tachyarrhythmia therapy with ventricular and atrial pacing and sensing. cardioversion/defibrillation therapies include a range of low- and high-energy shocks using a biphasic waveform and choice of multiple shock vectors. boston scientific implantable cardioverter defibrillators (icds) are intended to provide ventricular antitachycardia pacing (atp) and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias.

Singapore - English - HSA (Health Sciences Authority)

boston scientific asia pacific pte. ltd. - cardiovascular - these boston scientific cardiac resynchronization therapy defibrillators (crt-ds) are indicated for patients with the following risks:• sudden cardiac death caused by ventricular arrhythmias • heart failure with ventricular dyssynchrony. boston scientific crt-ds are also indicated for primary prophylaxis in heart failure patients.